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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYCornification and epidermal barrier defects are associated with a number of clinically diverse skin disorders. However, a suitable in vitro
model for studying normal barrier function and barrier defects is still lacking. Here, we demonstrate the generation of human epidermal
equivalents (HEEs) from human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). HEEs are structurally similar
to native epidermis, with a functional permeability barrier. We exposed a pure population of hESC/iPSC-derived keratinocytes, whose
transcriptome corresponds to the gene signature of normal primary human keratinocytes (NHKs), to a sequential high-to-low humidity
environment in an air/liquid interface culture. The resulting HEEs had all of the cellular strata of the human epidermis, with skin barrier
properties similar to those of normal skin. Such HEEs generated from disease-specific iPSCs will be an invaluable tool not only for
dissecting molecular mechanisms that lead to epidermal barrier defects but also for drug development and screening.INTRODUCTION
The major function of the skin is to form a permeability
barrier between an organism and its external environment.
Integrity and cohesion of the ‘‘bricks andmortar’’ structure
of the outermost layer of epidermis, the stratum corneum
(SC), is essential for terrestrial life, the survival of which ul-
timately depends on maintenance of permeability barrier
homeostasis (Elias, 1983; Kalinin et al., 2002; Segre 2003).
The SC is composed of corneocytes (‘‘bricks’’) encased in
a lipid-rich extracellular matrix (ECM; ‘‘mortar’’) (Nemes
and Steinert, 1999).
Corneocytes, which are composed of keratin microfi-
brils surrounded by cornified envelopes (CEs), are the
final products of a linear keratinocyte differentiation
pathway from a mitotically active stratum basale (SB)
through a transcriptionally active stratum spinosum (SS)
and a stratum granulosum (SG) that transitions into anu-
cleate SC cells. The CEs are formed from precursor pro-
teins directly beneath the plasma membrane. Following
membrane disintegration, Ca2+ influx activates transgluta-
minase, which irreversibly crosslinks CE proteins around
filaggrin-associated keratin filaments. These CEs combineStewith secreted and processed lipids to form a functional
epidermal barrier.
The lipids are packaged into lamellar bodies in the SG
cells. The lamellar body, with all its contents, is secreted
in response to barrier perturbation. The secreted lipids of
the SC are processed into lamellar membranes (Figures 1A
and 1B). Lamellar bodies also contain proteolytic enzymes
and antimicrobial peptides, which when secreted along
with lipid contribute to permeability barrier function
(reviewed in Elias, 2012).
Ichthyoses and atopic dermatitis are due to polymor-
phisms or mutations in genes that control keratinocyte
differentiation, cornification, or lipid metabolism. These
changes lead to defects in epidermal permeability barrier
homeostasis that range from mild (can be easily mistaken
for normal dry skin) to life threatening (Segre 2006; Smith
et al., 2006; Richard, 2004). Although ichthyosis-like dis-
eases are also present in animals and can be mimicked
in transgenic mouse models, there are still no suitable
in vitro models for these diseases.
Human epidermal equivalents (HEEs) are in-vitro-gener-
ated 3D models that are widely used in experimental set-
tings. However, their utility for addressing themechanismsm Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authors 675
Figure 1. Epidermal Permeability Barrier within the SC of Normal Human Skin
(A) Schematic drawing of normal human skin, depicting the epidermal permeability barrier within the SC.
(B–F) TEM demonstrates the components of a competent permeability barrier in normal human skin. Lipids are packaged into lamellar
bodies (LBs) in the SG cells.
(B) LBs (arrows) are present in the uppermost SG cells. These LBs are not discrete droplets, but rather are part of a tubular network
extending from the Golgi.
(C) LBs, with all their contents, are secreted into extracellular space (asterisks) between the uppermost SG cells. De, desmosome.
(D) Close-up of LB morphology.
(E) Lipid from LBs is processed into lipid bilayers (asterisk) by SC enzymes that require acidity, thus forming lipid structures that are
impermeable to passage of water and ions.
(F) Ceramide-based lipids bind to the CE (asterisk), forming the cornified lipid envelope (CLE).
Scale bars are noted in each panel.
Stem Cell Reports
Epidermal Permeability Barrier 3D In Vitro Modelof various skin disorders, or for drug development and
testing, has been limited by the fact that previously engi-
neered HEEs do not form a fully developed epidermal
barrier. In spite of advances in HEE engineering, such as
integratingmelanocytes (Nissan et al., 2011), macrophages
(Linde et al., 2012), or dermal fibroblasts (Itoh et al., 2013)
and pluristratified epidermis, issues involving the genera-
tion of a functional permeability barrier in vitro remain
unresolved. Further, in vitro studies have been limited
by the fact that only a limited number of HEEs can be
generated from one sample of epidermis, and the primary
keratinocytes generated from this sample may contain pre-
viously unidentified polymorphisms in genes that modify
epidermal growth, differentiation, or barrier development.
HEEs generated from immortalized keratinocytes develop
even less well than those generated from primary keratino-
cytes (Götz et al., 2012). Therefore, in order to develop a
HEE model that can be produced in an unlimited number
of genetically identical units, we turned to human embry-
onic stem cells (hESCs) and induced pluripotent stem
cells (iPSCs), primary cells that are capable of infinite
proliferation and whose genetic footprint can be fully
characterized.
We demonstrate here that by following an integrated,
highly reproducible four-step protocol, we were able to
differentiate hESCs/iPSCs into keratinocytes with gene-
expression profiles similar to those of normal human676 Stem Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authorskeratinocytes (NHKs, i.e., primary keratinocytes isolated
from biopsies of normal healthy skin). These hESC/iPSC-
derived keratinocytes were then used to generate HEEs
in an air/liquid interface culture exposed to sequential a
high-to-low humidity environment. HEEs generated from
hESC/iPSC-derived keratinocytes have a functional perme-
ability barrier similar to native human skin and are indis-
tinguishable from HEEs generated from NHKs under the
same condition. We are not aware of any other protocols
resulting in this functional endpoint.RESULTS
Reprogramming
Since the first iPSCs were derived, different reprogramming
approaches aimed at increasing their efficiency and mini-
mizing the potential for DNA damage have been developed
(reviewed in Bellin et al., 2012; Robinton and Daley 2012).
We used a nonintegrating, nonviral, synthetic, modified
mRNA system (Yakubov et al., 2010; Warren et al., 2010)
to reprogram human newborn fibroblasts (Figure S1 avail-
able online). In our hands, the reprogramming efficiency
was 0.76% (Figures 2A and S2), which is lower than that
reported byWarren et al. (2010).We chose two iPSC clones,
iKCL004 and iKCL011, that had a population doubling
time (PDT) similar to that of KCL034, a clinical-grade
(legend on next page)
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Epidermal Permeability Barrier 3D In Vitro ModelhESC line that we used as a control throughout all experi-
ments. Both iKCL004 and iKCL011 had a methylation
signature of PSCs, expressed pluripotency markers, and
were able to differentiate into cells of all three germ layers
in vivo (Figures 2B–2G and S3). Array comparative genomic
hybridization (CGH) did not detect any copy number
changes, using Promega male as a standard, over an
extended period of cell culture (>3 months) under feeder-
free conditions.
Efficient and Reproducible Differentiation of hESCs
and iPSCs into Keratinocytes
To recapitulate epidermogenesis, in the first step of kerati-
nocyte differentiation, which we termed ‘‘induction,’’ we
transferred a clinical-grade hESC line (KCL034) and two
iPSC lines (iKCL004 and iKCL011) from 5% O2 to atmo-
spheric O2, and exposed them to 25 ng/ml BMP4 and
1 mM of the carboxylic acid form of vitamin A, all-trans
retinoic acid (ATRA), for 7 days (Figure 3A). The lines did
not respond similarly to induction. Both iPSC lines ex-
pressed higher mRNA levels of the epidermal markers
integrin b4 (ITGB4) and keratin 14 (KRT14), suggesting
differentiation toward an epidermal lineage, whereas
hESC line KCL034 seemed to remain ‘‘undecided,’’ having
similar mRNA levels of these two epidermal markers and
a neural marker, oligodendrocyte lineage transcription
factor 2 (OLIG2; Figure 3B). In the next step, termed ‘‘selec-
tion,’’ we used native 3D decellularized human dermal
fibroblast (HDF) ECM as a growth-supporting platform.
This was done to mimic basement membrane (BM), which
is formed soon after epidermal induction during embr-
yogenesis (Figure S4). A week later, we purified epidermal
progenitor stem cells based on their preferential adherence
to collagen IV (Murray et al., 1979; Bickenbach and Roop,
1999). During the next ‘‘enrichment’’ step of our differenti-
ation protocol, the purified cells gave rise to a homoge-
neous population of keratin 14 (K14)+p63+ colonies, whichFigure 2. Generation and Characterization of Normal Human iPSC
(A) Trypan blue staining of colonies in one well of a six-well dish. Th
ments was 0.76%.
(B–D) DNA methylation analyses. Hierarchical clustering (B), methyla
both iKCL004 and iKCL011 have the methylation signature of PSCs. BJ,
for each cell line.
(D) Undifferentiated iKCL004 and iKCL011 cultured on HFF feeders
of PSCs.
(E) Expression of pluripotency markers is confirmed by alkaline phos
TRA-160, and TRA-1-81 in iKCL004 and iKCL011 lines.
(F) Differentiation of iKCL004 and iKCL011 into all three germ layers in
encapsulated and did not invade surrounding tissues. All sections w
brown (immunohistochemistry) or light blue (Alcian). Positive stainin
the teratoma tissue. Germ layer markers: Alcian blue/periodic acid Sc
and glial fibrillary acidic protein (GFAP) for ectoderm, and GATA4 and
See also Figures S1–S3.
678 Stem Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authorswas further amplified in the final ‘‘expansion’’ step of the
protocol (Figure 3C). p63 is a transcription factor that plays
a major role in maintaining the proliferative potential of
epithelial progenitors (reviewed in Blanpain and Fuchs,
2007). Whereas plating of cells on 3D HDF ECM rapidly
increased p63 mRNA expression, pluripotent markers,
such as the transcription factors Oct4 and nanog, steadily
decreased during differentiation (Figure 3D). K18, which
is expressed earliest during embryonic development, and
with its binding partner K8 can serve as a marker of simple
epithelium, was expressed at higher levels only during the
induction and selection steps, suggesting that the cells sub-
jected to our differentiation protocol were following a fate
similar to that which occurs for epidermal morphogenesis
during embryonic development. This four-step protocol
was highly reproducible. KRT14 expression increased
steadily during differentiation and there were no signifi-
cant differences among the three lines in multiple rounds
of the differentiation process (Figure 3E). The PD of
hESC/IPSC-derived keratinocytes did not differ much
from that of NHKs over a period of 5 weeks in culture
(Figure 3F).
hESC/iPSC-Derived Keratinocytes Are Very Similar to
Primary NHKs
Next, we compared enriched and expanded populations
(T3) of hESC/iPSC-derived keratinocytes with NHKs from
different donors in several different ways, and did not
find anymajor discrepancies. Differences in the expression
levels of KRT14 and p63 in multiple T3 populations of
hESC/iPSC-derived keratinocytes (n = 9; three biological re-
peats for each of three lines) and NHKs from three donors
were not statistically significant (Figure 4A). Flow-cytome-
try analysis of NHK and T3 populations of hESC/iPSC-
derived keratinocytes using K14 and integrin b4 as markers
did not identify any marked difference in the percentage
of double-positive (DP) cells; 95% of NHK, 87.8% ofs
e average reprogramming efficiency from two independent experi-
tion portrait (C), and principal component analysis (D) suggest that
parental HFFs. n = 3 biological replicates (rounds of differentiation)
and under feeder-free conditions display the typical morphology
phatase (AP) activity assay and immunostaining for NANOG, OCT4,
vivo is confirmed by detection of specific markers. Teratomas were
ere stained with hematoxylin and eosin (H&E). Specific stains are
g for mitochondrial complex IV type II confirms the human origin of
hiff (PAS)-stained cartilage and desmin for mesoderm, bIII tubulin
a-fetoprotein for endoderm.
Figure 3. Efficient and Reproducible Dif-
ferentiation of hESCs and iPSCs into Ker-
atinocytes
(A) Schematic of the differentiation proto-
col. T0 (day 0), T1 (day 7), T2 (day 14), and
T3 (day 28) represent time points at which
the cells were switched to a new culture
condition and/or collected for analyses.
(B) qPCR analysis measuring the expres-
sion of differentiation markers (epidermal:
ITGB4 and KRT14; neural: OLIG2) suggests
a difference in commitment toward epi-
dermal lineage at time point T1. n = 9 for
each cell line; each of three rounds of
differentiations (biological replicates) had
three technical replicates.
(C) Diversity is lost at later stages, and cell
colonies at the enrichment step are uni-
formly positive for keratinocyte markers
K14 (red) and p63 (green).
(D) qPCR analyses measuring expression of
differentiation markers at T0, T1, T2, and T3
of the differentiation protocol. Expression
of pluripotency markers OCT4 and NANOG
is diminished by the end of differentiation,
whereas KRT18 and p63 mRNA levels reflect
stages during epidermogenesis. n = 9 for
each cell line; each of three rounds of
differentiations (biological replicates) had
three technical replicates.
(E) Levels of KRT14 mRNA expressed during
three rounds of differentiation at four
different time points for each of lines
demonstrate the reproducibility of the
protocol. Absolute quantification was per-
formed using the ddCt method. GOI ex-
pression was normalized to the geometrical
mean of two HK genes (GAPDH and ElF4A2).
The SEM was calculated for mean expression
in KCL034, iKCL004, and iKCL011. n = 9 for
each cell line; each of three biological
replicates/rounds of differentiations had
three technical replicates.
(F) The proliferation rate of hESC/iPSC-
derived keratinocytes shows no marked
difference compared with freshly isolated primary NHKs over a period of 5 weeks. Statistical significance was calculated for each passage
using two-way ANOVA with Sidak’s multiple comparison test. Data are presented as a blank adjusted mean with SD (n = 3 biological
replicates for each cell line).
See also Figure S4.
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were K14+/integrin b4+ (Figures 4B and S5). Finally, we used
the HumanHT-12 Expression BeadChip whole-genome
expression array, which provides coverage for more than
47,000 transcripts and known splice variants, to compare
the transcriptomes of undifferentiated hESCs/iPSCs (T0),
hESC/iPSC-derived keratinocytes (T3), and NHKs fromStetwo different donors. The T0 and T3 transcriptomes were
analyzed as biological replicates from three independent
differentiation runs for each of three cell lines (KCL034,
iKCL004, and iKCL011). Principal component analysis
identified an expected pattern: hESC/iPSC-derived kera-
tinocytes at T3 were grouped together with NHKs and
were dissimilar to undifferentiated hESCs/iPSCs at T0m Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authors 679
Figure 4. Profiling of hESC/iPSC-Derived Keratinocytes
(A) qPCR analyses measuring expression of KRT14 and p63 in hESC/iPSC-derived keratinocytes at T3 (n = 9; three rounds of differentiation
for each of three lines) and NHKs (n = 2) found no significant difference between the two groups. Multiple t tests. Statistical significance
was determined using the Holm-Sidak method. For KRT14, p = 0.120881; for p63, p = 0.155472.
(B) Populations of hESC/iPSC-derived keratinocytes at T3 have a similar percentage of K14+/integrin b4+ cells as NHKs. The percentage is
an average from three rounds of differentiation for each of the three lines. At T0, no K14+/integrin b4+ cells were detected. Fluorescence-
activated cell sorting (FACS) images represent one of the three rounds.
(C and D) Scatterplots showing the relative expression of all genes on the chip.
(C) Global gene-expression profiles of NHKs from two donors (NHK1 and NHK2) shown as a scatterplot against each other.
(legend continued on next page)
680 Stem Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authors
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Epidermal Permeability Barrier 3D In Vitro Model(Figure S6). As an average of three biological replicates, the
transcriptome of iKCL011-derived keratinocytes at T3 was
closer to the transcriptome of NHKs than to keratinocytes
derived from iKCL004 or KCL034. A scatter analysis of
gene expression in NHKs from two different donors
(NHK1 and NHK2) found that 939 transcripts (2.00%)
differed by >2-fold (Figure 4C). An average of these two
was then compared with an average of three biological
replicates from each of the three lines at T3. The keratino-
cytes derived from iKCL011 differed by >2-fold in only
155 transcripts (0.33%) from NHKs by >2-fold, whereas
iKCL004 (636 transcripts, 1.35%) and KCL034 (1,604
transcripts, 3.41%) were more distinct (Figure 4D). Among
all transcripts that were different from NHKs, only 122
(0.26%) were common to all hESC/iPSC-derived keratino-
cytes at T3 (Figure 4E). We profiled these 122 transcripts
using the GeneGo database (Thomson Reuters) for
Pathway Maps, Process Networks, Gene Ontology Net-
works, and Disease Biomarkers list, and found that 34
(0.07%) of them might have relevance to keratinocyte
biology (Tables S1–S5, S6, and S7).
We also looked at how reprogramming and differentia-
tion changed human leukocyte antigen (HLA) gene expres-
sion (Figure 4F). Although parental HDFs do express HLA
class I, the reprogrammed clonal lines iKCL004 and
iKCL011 do not, similarly to hESC line KCL034. Differenti-
ation into keratinocytes changed the global pattern.
Notably, HLA class I genes were turned on, implying that
the recipients of epidermis generated from the hESC-
derived keratinocytes as an off-shelf product would be in
need of immunosuppressive therapy, whereas that may
not be the case with iPSC-based autografts.
hESC-derived keratinocytes exhibit an epidermal tran-
scription program, and p63 is considered to be the main
transcription regulator of epidermogenesis and essential
for epidermal commitment of hESCs (Blanpain and Fuchs,
2007; Aberdam et al., 2007; Medawar et al., 2008; Pozzi
et al., 2009; Crum and McKeon 2010; Vanbokhoven
et al., 2011). Therefore, we compared the expression
profiles of 96 genes that, according to the NCI Pathway(D) Global gene-expression profiles of hESC/iPSC-derived keratinocyt
tiation for each line) shown in scatterplots against NHKs (average of n
as XY coordinates for each sample. Yellow lines indicate boundaries o
(E) Venn diagram of the transcripts with a 2-fold relative expression
keratinocytes at T3 shows that 122 out of >47,000 were common to
(F) Heatmaps showing relative expression patterns across multiple
searching for ‘‘HLA’’ within the ‘‘Gene Symbol’’ annotation, and p63-r
in the NCI Pathway Interaction database. The colors of the heatma
average for that gene across the samples. The values are the average
and T3. Transcripts for NHKs from two different donors are shown in
transcriptional network heatmap.
See also Figures S5 and S6, and Tables S1–S5, S6, and S7.
SteInteraction Database, constitute the p63 transcriptional
network. Of these genes, only three (ADA [OMIM: 608958],
SMARCD3 [OMIM: 601737], and YWHAQ [OMIM: 609009]
had R2-fold higher expression in NHK from two donors
than in all biological replicates of hESC/iPSC-derived
keratinocytes at T3. Similarly, only three of those 96 genes
(BBC3 or PUMA [OMIM: 605854], CDKN1A or p21 [OMIM:
116899], and SP1 [OMIM: 189906]) had R2-fold higher
expression in hESC/iPSC-derived keratinocytes at T3 than
in NHKs from two donors. None of these six genes are
known to be essential for epidermogenesis, although they
may be indirectly involved.
HEEs with a Functional Epidermal Permeability
Barrier Generated In Vitro
Molecular characterization suggested that our highly
reproducible protocol for differentiating hESCs/iPSCs into
keratinocytes yields a fairly pure population of cells that
are very similar to NHK. To test the capability of hESC/
iPSC-derived keratinocytes to generate multilayered
epithelium in vitro, we used the HEE model developed by
R.S., A.C., D.C., M.H., L.C., S.D. Peckenpacker, K. Park,
Y. Uchida, K.R. Feingold, P.M. Elias, D.I., and T.M.M.
(unpublished data). The HEEs generated using this proto-
col developed in vitro all of the cellular strata seen in the
human epidermis. Since they also developed normal
barrier properties in vitro, there was no need to implant
the organotypic cultures into immunodeficient mice,
which is a commonly used technique (Del Rio et al.,
2002). We assessed the integrity of the stratifying cultures
by measuring the transepithelial electric resistance (TEER),
which indicates changes in the transcellular and para-
cellular permeability of epithelial/epidermal in vitro cell
cultures. Within 2 weeks, the TEER in all cultures reached
>1,000 U, indicating the formation of a permeability
barrier and multilayered epithelia (Figures 5A and 5B).
Differentiation markers were normally expressed and
located (Figures 6A–6D). Since our system does not contain
mixed fibroblast-keratinocytes cultures, the basement
membrane zone (BMZ) generated by this system cannotes at T3 (average of n = 3 biological replicates/rounds of differen-
= 2). Normalized linear expression levels for each probe are plotted
f a 2-fold relative expression difference.
difference from NHKs in KCL034-, iKCL004-, and iKCL011-derived
all three lines.
samples for specific gene lists. HLA genes were selected by text
elated genes were identified from the p63 transcriptional network
ps indicate high (yellow) or low (blue) expression relative to the
of three independent runs for KCL034, iKCL004, and iKCL011 at T0
dependently on the HLA heatmap, and as an average on the p63
m Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authors 681
Figure 5. Pluristratified HEEs Generated In Vitro from hESCs and iPSCs
(A) The TEER during HEE formation over a period of 14 days reflects permeability barrier formation (n = 4 for NHK, n = 12 for each of lines;
each point represents an average of measurements from three different spots). Error bars represent SD. Only 14-day-old HEE cultures that
displayed a TEER of >1,200 ohm cm2 were used for subsequent analyses unless indicated otherwise.
(B) H&E staining demonstrates normal morphology with the presence of all epidermal layers regardless of the source of keratinocyte
population. SB, stratum basale; SS, stratum spinosum.
Stem Cell Reports
Epidermal Permeability Barrier 3D In Vitro Modelbe equivalent to the BMZ of human skin. Nevertheless, in
our 3D cultures, basal-layer keratinocytes were secreting
ECM proteins, such as laminin, and assembling a BMZ-
like structure (Figures 6E and 6F).
Next, we examined the epidermal permeability barrier.
Lipid secretion appeared normal. Lamellar bodies and
extensive intercellular bilayers were detected in all cultures
(Figure 7A). The endoplasmatic reticulum (ER) Ca2+ store,
which is essential for normal keratinocyte signaling and
differentiation (Callewaert et al., 2003; Celli et al., 2012),
was detectable at day 8 of the culture (Figure 7B). Typically,
the Ca2+ gradient for normal epidermis has low levels in
the SB and lowest levels in the SS, followed by an increase
in extra- and intracellular Ca2+ that peaks within the SG
(Elias et al., 2002). In terminally differentiated air-lifted
cultures at day 14, HEEs generated from NHKs and hESC
(KCL034)-derived keratinocytes had the greatest density
of Ca2+ precipitates in the SG, whereas precipitates were
somewhat more diffuse in HEEs generated from iPSC-
derived keratinocytes (Figure 7C). However, the lanthanum
perfusion assay, which is used to depict pathways of water
movement through epidermis, demonstrated a functional
permeability barrier in all cultures: the passage of elec-
tron-dense lanthanum tracer was blocked by the epidermal
lipid barrier at the SG/SC interface and was not detected
in the SC (Figure 7D).DISCUSSION
We have described a stepwise protocol for manufacturing
in vitro HEEs, with all of the cellular strata and apparently682 Stem Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authorsnormal barrier properties seen in the human epidermis,
from hESCs and iPSCs.
When manipulating the cellular fate of pluripotent cells
in vitro, it is crucial to have a thorough understanding of
the embryonic morphogenesis of the target tissue in order
to achieve efficient production of the desired cell type (Hay
et al., 2008; Cheng et al., 2012). Epidermal morphogenesis
andhomeostasis are relativelywell described (Blanpain and
Fuchs, 2009; Simpson et al., 2011). After gastrulation, the
embryo surface emerges as a single layer of neuroectoderm,
which will ultimately specify the nervous system and skin
epithelium. This decision is guided by Wnt signaling,
which blocks the ability of the ectoderm to respond to
fibroblast growth factors (FGFs). In the absence of FGF
signaling, the cells express bone morphogenetic proteins
(BMPs) and become fated to develop into epidermis. In
contrast, neural fate develops when, in the absence of a
Wnt signal, the ectoderm is able to receive and translate
activating cues by FGFs, which then attenuate BMP
signaling through inhibitory cues (Chang and Hemmati-
Brivanlou, 1998; Stern, 2005). Similarly to our protocol,
most of the published protocols for differentiation of
PSCs (either mouse or human) into keratinocytes follow
this strategy (referenced in Figure S6). We introduced a
step in which we purified epidermal progenitor stem cells
based on their preferential adherence to collagen IV (Mur-
ray et al., 1979; Bickenbach and Roop, 1999). In our hands,
this step, which is a kind of physiological purification
step that puts a minimal stress on the cells, resulted not
only in a higher yield of hESC/iPSC-derived keratinocytes
but also in a purified population that was highly homo-
geneous and similar to NHKs (Figure 2). Homogeneous
Stem Cell Reports
Epidermal Permeability Barrier 3D In Vitro Modelpopulations of keratinocytes differentiated from disease-
specific iPSCs would be advantageous for addressing the
effects of suchmutations on keratinocyte biology (Mildner
et al., 2010; Simpson et al., 2010).
Although a link between the level of ambient humidity
and barrier development has been described in both ani-
mals (Hanley et al., 1997; Kömüves et al., 1999) and human
premature infants (Agren et al., 2006), and then recapitu-
lated in vitro with NHKs (Thakoersing et al., 2010), the
exact molecular mechanism is still unclear. A limited num-
ber of studies have addressed the relationship between
environmental humidity and barrier function in postnatal
epidermis (Takei et al., 2013; Katagiri et al., 2003; Sato et al.,
2002; Denda et al., 1998), and the results warrant further
work. Regardless, the model that we describe here would
have an unprecedented advantage for elucidating the
molecular mechanisms of barrier development, perturba-
tion, and recovery, as well as how mutations of genes
involved in cornification and lipid metabolism affect
permeability barrier homeostasis (Mildner et al., 2010;
Simpson et al., 2010).
Previous HEE models have developed some barrier prop-
erties (Gschwandtner et al., 2013; Thakoersing et al., 2012;
Ponec et al., 2001). The technique presented here is an
advance from previously published HEEs because it is
able to produce a HEE that not only shows morphologic
changes associated with barrier establishment but also
demonstrates the essential functional properties seen in
skin with a functional barrier. The HEEs described above
provide an effective block against water permeation, as
evidenced by their ability to block lanthanum and form a
calcium gradient. Further, this 3D model of HEEs with a
functional permeability barrier is highly reproducible
and has the potential to be easily scaled up and adapted
to cGMP requirements for the use in regenerative and
aesthetic medicine, as well as drug development. The
recent (March 2013) European Union ban on the import
and sale of cosmetics containing ingredients tested on
animals will increase the demand for efficient and cost-
effective alternative in vitro models that would not com-
promise consumer safety. HEEs with a functional perme-
ability barrier generated completely in vitro from either
hESCs or iPSCs, as described here, might present the best
available answer (Küchler et al., 2013).EXPERIMENTAL PROCEDURES
mRNA Synthesis and Modifications
The intronless coding sequences (CDSs) of OCT4, SOX2, KLF4,
c-MYC, and LIN28 were retrieved from the National Center for
Biotechnology Information (NCBI). As previously described by
Warren et al. (2010), a KOZAK translational initiation signal was
added in the 50 UTR, whereas the 30 UTR was terminated with anStealpha-globin-driven oligo(dT) sequence for templated addition
of a polyA tail. The CDSs were then codon optimized with the
use of GeneOptimizer expert software (GENEART/Life Technolo-
gies). Codon optimization allows more efficient transcription
by avoiding RNA secondary structures, adjusting GC content,
and removing splice-sites. The gene encoding the destabilized
enhanced GFP (d2EGFP) codon from pRVGP-d2EGFP vector
(Addgene) and optimized OCT4, SOX2, KLF4, c-MYC, and LIN28
CDSs were synthesized and subcloned (GENEART/Life Technolo-
gies) into the pTNT plasmid vector, which was specifically de-
signed for in vitro expression (Promega). Plasmids were linearized
with BamHI. PCR templates were generated from the linearized
plasmids using the same upstream primers for all six constructs
and six different gene-specific, downstream T120-heeled reverse
primers for addition of the poly(A) tail. Quality control of the
PCR reaction was performed by capillary electrophoresis (Agilent
Bioanalyzer). The templates were transcribed with T7 polymerase
and further modified according to Warren et al. (2010). Modifica-
tions included the complete substitution of 5-methylcytidine
(5mC) for cytidine and the substitution of pseudouridine (psi)
for uridine to increase mRNA viability and ectopic protein expres-
sion. Furthermore, to promote efficient translation and increase
mRNA half-life, a synthetic 50 guanine cap 30-0-Me-m7G(50)
ppp(50)G was added and 50-triphosphates were eliminated by
Antarctic phosphatase treatment. The DNA template was removed
with DNase, and single-strand RNA (ssRNA) was purified with
spin columns. Quality control of the purified ssRNA product was
performed by capillary electrophoresis (Agilent Bioanalyzer; Fig-
ure S1). An ‘‘mRNA cocktail’’ containing OCT4, SOX2, KLF4,
C-MYC, LIN28, and d2eGFP in molar ratios of 3:1:1:1:1:1 at a final
concentration of 100 ng/ml was prepared (AmsBio), aliquoted for
single use, and frozen in single-use aliquots.Reprogramming
Mitotically inactivated foreskin fibroblasts (NuFF from donor 11;
AmsBio) were used as feeder cells and plated at a density of
2.5 3 105/well of a six-well dish coated with CELLstart (Life
Technologies). Human neonatal foreskin fibroblasts BJ (ATCC,
CRL-2522) were plated onto feeders 24 hr later at a density of
7,000/well. For each four wells to be transfected, 25 ml of RNAiMAX
(Sigma), a lipofectamine transfection reagent, was diluted in 225 ml
of Opti-MEM (Life Technologies) and mixed with 50 ml of mRNA
cocktail diluted in 200 ml Opti-MEM. The complex was incubated
at room temperature for 15min before 120ml was added dropwise
into each of four wells to be transfected. The culture medium was
refreshed 4 hr later with complete Pluriton medium (Stemgent)
supplemented with 300 ng/ml B18R (eBioscience). Transfection
was repeated for 17 consecutive days. On days 6–17, Pluriton was
preconditioned with NuFF feeders for 24 hr and supplemented
with 300 ng/ml B18R and 0.5 mM Na-butyrate. On days 18–21,
potential iPSC colonies were left to expand in complete Pluriton
with no other supplements. Ten colonies were picked based on
morphology on day 21, transferred onto human foreskin fibroblast
(HFF) feeders in KOSR-XF medium (Life Technologies), and
expanded. Two clones with a similar growth rate, iKCL004 and
iKCL011, were further characterized. The cells were cultured at
5% O2, 37
C, 5% CO2 throughout the reprogramming.m Cell Reports j Vol. 2 j 675–689 j May 6, 2014 j ª2014 The Authors 683
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hESC line KCL034 was derived and characterized as previously
described (Jacquet et al., 2013; Stephenson et al., 2012). Expression
of pluripotency markers and capability to differentiate into cells
of three germ layers were confirmed for both iKCL004 and
iKCL011 by methods that are routinely used for hESC lines in
our derivation center.
PSC lines were cultured under standard feeder-free conditions
on BD Matrigel hESC-qualified matrix (Becton Dickinson) in
mTESR1 medium (StemCell Technologies) under hypoxic (5% O2)
conditions.Methylation Assay
Genomic DNA was isolated from BJ parental fibroblasts (negative
control), KCL034 (positive control), iKCL004, and iKCL011. Each
sample of 500 ng DNA was bisulfite treated (EZ Zymo DNA Kit)
according to the manufacturer’s recommendations optimized
for 450k array. Epigenome-wide methylation (>480,000 CpG sites)
was analyzed using the Infinium Human Methylation 450 Bead-
ChipKit (Illumina) inbiological triplicates for each line.GenoSplice
Technology performed quality control, processing, and further
analyses of the data.3D HDF ECM
Preparation of decellularized 3D ECMwas performed as previously
described (Ilic et al., 2012).Differentiation Protocol
To induce differentiation, undifferentiated PSCs were transferred
into a 20%O2 atmosphere environment and treated with mTESR1
basal media supplemented with 1 mM ATRA (Sigma-Aldrich) and
25 ng/ml BMP4 (R&D) for 7 days (Induction). To select for cells
with early acquisition of ectodermal fate, the cells were harvested
and replated onto freshly prepared 3D HDF ECM at a density of
5–103 103 cells per cm2 and grown in Dulbecco’s modified Eagle’s
medium/Ham F12 (3:1; Life Technologies) supplemented with
1 mM ATRA and 25 ng/ml BMP4 for a further 7 days (Selection).
To enrich for putative epidermal progenitors, rapid adhesion to
type IV collagen-coated dishes was used, and the rapidly adhering
cells were cultured in defined keratinocyte-SFM supplemented
with 1 mM ATRA for 7 days (Enrichment). After that, the cells were
cultured in EpiLife medium (Life Technologies) for a further
7 days (Expansion) before final harvest and analysis.Proliferation Assay
All three lines andNHKswere seeded in six-well plates in triplicates
at a constant density of 4 3 105 per well. Every 7 days, cells wereFigure 6. The Distribution of Epidermal Markers in HEEs Mirrors t
(A) Immunostaining for three markers of keratinocyte terminal differe
expressed at the appropriate site, denoting normal epidermal differe
(B–D) Immunostaining for K14 (basal layer) and K10 (suprabasal layer
general) (D) demonstrates normal epithelial stratification in all HEE
(E and F) Basal layer keratinocytes express laminin (E) and form BM
stratum basale; TM, transwell membrane. Yellow arrowheads point to
Steharvested and the total number was counted. The cells were
then subcultured at the density described above. This cycle was
repeated for five passages. Average PDs were calculated for each
line and control at each passage according to the following
formula:
PD = (log 2)  1(logNt  logN0), where Nt = cell number at
harvest and N0 = cell number plated (4 3 105). The total PD level
was calculated as the cumulative of average PDs for five passages.
The PDT was calculated according to the following formula:
PDT = I/PD, where I = interval (days) between the passages (7).
Immunostaining
Samples were processed as previously described (Ilic et al., 2007;
Stephenson et al., 2012). The following antibodies were used:
rabbit anti-K14, rabbit anti-filaggrin, rabbit anti-involucrin, and
rabbit anti-loricrin (all from Covance); rabbit anti-laminin
(DAKO); mouse anti-p63 (Santa Cruz Biotechnology); rabbit anti-
fibronectin, mouse anti-collagen IV, mouse anti-collagen VII, and
rabbit anti-desmocollin 1 (all from Sigma-Aldrich); and rabbit
anti-p63, mouse anti-K10, and rabbit anti-collagen I (all from
Abcam). Secondary antibodies were obtained from Jackson Immu-
noResearch and Life Technologies.
Flow Cytometry with Confocal Imaging
Cells were incubated with PE-conjugated rat anti-CD104 (integrin
b4) antibody (BD PharMingen) for 1 hr, washed, fixed with 4%
(v/v) paraformaldehyde, and permeabilized with 0.1% Triton
X-100 in PBS. The samples were then incubated with fluorescein
isothiocyanate (FITC)-conjugated mouse anti-K14 antibody
(Abcam) for 1 hr, washed and incubated with Hoescht 33342
(Life Technologies) for 5 min. To set the gating, fluorescence
minus one (FMO) and single-stained compensation controls
were also prepared. For acquisition, 1 3 106 cells/per sample
were resuspended in 100 ml of 1% BSA/PBS. The data were acquired
on an ImageStreamX analyzer and analyzed with IDEAS software
(Amnis).
Quantitative RT-PCR
Data for quantitative PCR (qPCR) analysis were collected from
three independently performed differentiation rounds for each
of the cell lines. Total RNA extraction was performed at T0, T1,
T2, and T3 time points using the RNeasy kit (QIAGEN). For
cDNA preparation, the QuantiTect Reverse Transcription Kit (-
QIAGEN) was used. The primers are listed in Figure S7. KAPA
SYBR FAST Universal 23 qPCR Master Mix (Kapa Biosystems)
was used to set up the qPCR and run on a real-time PCR 7900HT
system (Applied Biosystems). All reactions were run in triplicates.
The data were collected and analyzed using GUSB and b-actinhat in Human Skin
ntiation: filaggrin, loricrin, and involucrin. Each of these markers is
ntiation.
s) (B), desmocollin 1 (suprabasal layers) (C), and p63 (basal layer in
cultures.
Z-like structure (F). BM, basement membrane; Cy, cytoplasm; SB,
laminin-positive staining of BM.
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Figure 7. HEE with a Functional Permeability Barrier
(A) Lipid bilayer formation assessed with TEM. Arrows, lamellar bodies; asterisks, lipid bilayers. Upper row: normal lipid secretion between
the SG and SC is seen in all cultures. Middle row: LBs are seen in the SG of all cultures (arrows). LB morphology was normal in all cultures,
although it appeared slightly smudged in KCL034. Bottom row: lipid was successfully processed into lipid bilayers (asterisks) in all cultures.
Like LB morphology, lipid bilayer morphology was normal in all cultures, although it seems slightly disrupted in KCL034.
(B) ER Ca2+ sequestration at day 7 of HEE culture in cells transfected with the ER-targeted Ca2+ sensor D1ER. Data are presented as the mean
of the intensity ratio (I) between the yellow-channel (higher Ca2+) and blue-channel (lower Ca2+) images (I(yfp)/I(cfp)) ± SEM. Higher
ratios denote higher Ca2+ stores in the ER. n = 10–14 cells from two biological replicates in each group. Significance was calculated using a
one-way ANOVA. Distributions with p < 0.05 were assumed to be statistically different based on unpaired t tests between the populations.
(C) The epidermal Ca2+ gradient captured on TEM as electron-dense Ca2+ deposits at day 14. Arrows indicate the direction from the basal
layer toward the SC. Ca2+ precipitates (black deposits) denote the presence of Ca2+ in the tissue. Precipitates are seen in the viable SG but
are absent from the SC, denoting a functional barrier to the passage of water and ions.
(D) Permeability barrier integrity assessed by lanthanum perfusion. Lanthanum is visualized as electron-dense deposits in the extracellular
spaces of the viable SG (arrowheads), demonstrating that lanthanum and, by extension, water and other small ions can pass between
keratinocytes in this stratum. In contrast, lanthanum spreads along the base of the SC, but cannot penetrate further into the SC because a
functioning lipid barrier is blocking its movement upward. All cultures demonstrated a functional permeability barrier.
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quantified using the ddCT method.Whole-Genome Gene-Expression Array
Total RNA from T3 cell populations and control primary NHKs
were reverse transcribed into cDNA using SuperScript III Reverse
Transcriptase (Life Technologies). In vitro transcription of
biotin-labeled antisense RNA (aRNA) was performed with the
TargetAmp-Nano labeling kit (Epicenter), and purification was
performed with the RNeasy Mini Kit (QIAGEN). The quality and
quantity of the resultant biotin-labeled aRNAs were assessed using
a Bioanalyzer (Agilent) and Qubit Fluorometer (Life Technologies).
A total amount of 750 ng of biotin-labeled aRNA in a 5 ml volume
was then used for the HumanHT-12 Expression BeadChip
whole-genome, gene-expression direct hybridization assay system
(Illumina) according to the manufacturer’s instructions and run
on the iScan system (Illumina).HEEs
A suspension of 0.25 3 106 neonatal NHKs or hESC/iPSC-derived
keratinocytes was seeded on a CELLstart CTS (Invitrogen)-
coated 12-well 0.4 mm PET Millicell Hanging Cell Culture Insert
(Millipore) in CnT.BM.1 medium with CnT-07 supplement
(CELLnTEC). Three days after seeding, the medium was switched
to CnT-BM.3 medium with CnT-02-3DF with supplement
(CELLnTEC). On day 4, the HEEs were air exposed by feeding
the insert from bottom of the well only. HEEs were grown in
a humidified (3100% relative humidity) or dry (30%–50%
relative humidity) incubator at 37C (R.S., A.C., D.C., M.H.,
L.C., S.D. Peckenpacker, K. Park, Y. Uchida, K.R. Feingold,
P.M. Elias, D.I., and T.M.M., unpublished data). The TEER was
measured with an epithelial voltohmmeter (EVOM; World Preci-
sion Instruments).ER Ca2+ Sequestration
Cells were transfected with the ER-targeted cameleon-based Ca2+
sensor D1ER (a gift from Dr. Amy Palmer; Palmer and Tsien,
2006) using the lipid-based TransIT transfection reagent (Mirus)
at a 1:3DNA/TransIT ratio. Transfection complexeswere assembled
30 min prior to cell plating by adding 1 ml D1ER (at a 1.3 mg/ml
concentration) and 3 ml transfection reagent per 100 ml serum-
free OptiMem. Cells were resuspended in low-calcium 154 CF
medium supplemented with 0.03 mM Ca2+ (GIBCO) at a density
of 0.5 3 106 cells per 1.5 ml. Transfection complexes were added
to the suspension at a 100 ml:1 ml complex/cell suspension ratio
and gently mixed by pipetting. The cells were then plated into
12-well inserts precoated with CELLstart at a 0.5 3 106 cells per
insert density and left with the transfection complexes overnight.
The medium was then switched to CnT.BM.1 medium with
CnT-07 supplement (CELLnTEC) for 3 days. Dual-channel fluo-
rescence measurements were recorded using a Zeiss LSM Meta
confocal system (Zeiss).Transmission Electron Microscopy
Samples were processed for transmission electron microscopy
(TEM) as previously described (Ilic et al., 2007; Tu et al., 2012).SteACCESSION NUMBERS
The methylation data have been deposited in the Gene Expres-
sion Omnibus under accession number GSE55006, and expres-
sion array data have been deposited under accession number
GSE55898.
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Götz, C., Pfeiffer, R., Tigges, J., Blatz, V., Jäckh, C., Freytag, E.M.,
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